Lung Cancer

Jennifer Grey's 94-year-old mother died on the Fourth of July after receiving a lung cancer diagnosis a week prior, choosing to end her life with dignity.

Jennifer Grey announced her 94-year-old mother's death on the Fourth of July, a week after her lung cancer diagnosis, noting it was by her own choosing and with dignity.

A June report by the New York State Department of Health found no link between Seneca Meadows landfill and elevated lung cancer diagnoses in two nearby census tracts from 1996-2021. The report failed to address public concerns about the landfill's potential health impacts.

David Peterson, a Stage 4 lung cancer patient, underwent a double lung transplant at Northwestern Medicine's DREAM program, the only U.S. hospital performing this treatment for such cases, after traditional therapies failed. The procedure, inspired by pandemic-era lung transplant techniques, saved his life.

St. Peter's Health Partners is utilizing new robotic technology to enhance early detection of lung cancer. The tool aims to improve identification of the disease at an earlier stage.

Lam Wing-kee, a Hong Kong bookseller who sold material critical of China, died at age 70 after battling lung cancer. His death marks the loss of a figure known for defying Chinese authorities through his bookstore activities.

The article discusses the 'double-decker sandwich' caregiving challenge where couples care for both sets of parents, along with heat risks for older adults, non-smoking lung cancer causes like radon, and a Vermont woman's global teddy bear initiative for traumatized children.

The article discusses the 'double-decker sandwich' caregiving challenge where couples care for both their parents and their in-laws, along with risks of heat waves for older adults, non-smoker lung cancer risks, and a teddy bear initiative for children in crisis. Experts provide strategies for managing caregiving duties and highlight health dangers and prevention methods.

The article discusses the psychological challenges faced by Hong Kong cancer patients and highlights support programs that are transforming treatment approaches. It features Sasa Hui Yuen-sim, a 67-year-old retiree diagnosed with breast cancer in June 2024 and lung cancer the following year, emphasizing the mental toll of her battle with multiple cancers.

GSK acquired Nuvalent, a biotech company with two drugs under FDA review for targeting genetic mutations in lung cancer, for $10.6 billion. Approval decisions for the drugs are expected later this year.

GSK is acquiring lung cancer biotech Nuvalent in its largest deal in over a decade. The all-cash transaction provides GSK with two late-stage lung cancer drugs under FDA review.

British drugmaker GSK, led by new CEO Luke Miels, has agreed to acquire US-based cancer treatment firm Nuvalent for $10.6 billion. The deal aims to strengthen GSK's oncology portfolio, with Nuvalent developing three late-stage lung cancer medications.

British drugmaker GSK has agreed to acquire US-based cancer treatment company Nuvalent for $10.6 billion to expand its oncology portfolio. The deal includes Nuvalent's three late-stage lung cancer medications.

A study found that switching from cigarettes to vapes does not significantly reduce the risk of lung cancer.

A study found that switching from cigarettes to vapes does not significantly reduce the risk of lung cancer. The research challenges the assumption that vaping is a safer alternative in terms of lung cancer prevention.

Lung cancer cases among Hong Kong women have increased by 20% over two decades despite lower smoking rates compared to men. Experts highlight genetic factors and call for citywide screenings to detect the disease earlier.

A new discovery related to lung cancer may help doctors predict and prevent the disease. ABC News' Dr. Tara Narula highlights this development as a potential aid in combating the world's deadliest cancer.

A retired San Francisco firefighter died from stage 4 lung cancer after Blue Shield denied his treatment claims. He spent his final months appealing to San Francisco's Health Service Board to intervene in the insurance dispute.

A retired San Francisco firefighter died from stage 4 lung cancer after Blue Shield denied approval for treatment. He spent his final months appealing to the City and County of San Francisco's Health Service Board to intervene.

Cancer drugmaker Parabilis is seeking $475 million through a US IPO. The article references an MRI scan depicting lung cancer in the left pulmonary lobe.

A retired San Francisco firefighter died from stage 4 lung cancer after Blue Shield denied treatment claims. He appealed to the City and County of San Francisco's Health Service Board to intervene but was unsuccessful.

Cary Hatch, a Stage 4 lung cancer survivor, advocates for inexpensive radon testing to prevent lung cancer. Radon, a radioactive gas, is the leading cause of lung cancer in non-smokers and second overall. She highlights affordable testing kits and mitigation systems to reduce exposure.

A new study on the pancreatic cancer drug daraxonrasib shows it could double survival rates for over 90% of patients. Researchers are investigating its potential effectiveness in lung, ovarian, and colorectal cancers.

A Chinese lung cancer drug reduced the risk of death by 34% in a late-stage trial, extending survival by four months when combined with chemotherapy for squamous non-small-cell lung cancer. The results highlight China's growing pharmaceutical innovation, alongside global advancements like Eli Lilly's obesity drug and a pancreatic cancer treatment.

An experimental lung cancer drug developed by Akeso and Summit Therapeutics reduced the risk of death by 34% in a late-stage trial conducted in China, according to recently released data.

A Hong Kong app serves as a vital lifeline for 76,000 cancer patients. Susan Tam, a 70-year-old diagnosed with lung cancer, faced severe skin rashes from her medication and tried various remedies without success.

The U.S. adult cigarette smoking rate reached an all-time low of 9% in 2025, according to CDC survey data. The decline is attributed to higher taxes, smoking bans, and public health campaigns, though e-cigarette use remains steady at 7%. Advocates highlighted setbacks from Trump administration cuts to anti-smoking initiatives.

The article highlights positive data presented at the ASCO annual meeting for Bristol in multiple myeloma and Pfizer in lung cancer. STAT's coverage focuses on key developments from the event, emphasizing advancements in cancer treatments.

A new study found that GLP-1 weight-loss medications may slow the spread of several obesity-related cancers, including breast, prostate, lung, colorectal, and liver cancers.

A new gene-activity 'clock' tool predicts biological ageing in rodents and monkeys, and human time to death. The article also notes zebrafish sleep in stages similar to humans and highlights efforts to intercept lung cancer before it starts.

Sen. Dick Durbin shares his personal experience of losing his father to lung cancer and highlights his legislative efforts to reduce smoking, including a 1988 ban on smoking on domestic flights. He criticizes Trump for allowing Big Tobacco to target children.

A new 'interception' drug trial aims to prevent lung cancer before it develops, as reported in a 2026 Nature study. The research focuses on stopping the world's deadliest cancer through early intervention.

Lung cancer, previously predominantly affecting men, is now recognized as a distinct disease in women. The article highlights ongoing disparities in research, detection, and treatment for women with lung cancer.

Lung cancer cases are rising fastest in middle-income countries like China due to high smoking rates and polluted air. Africa is projected to follow a similar trajectory, shifting the global lung cancer burden away from high-income nations.

A study published in Nature on 27 May 2026 highlights that advancements in early detection, innovative drugs, and a deeper understanding of lung cancer are leading to better patient outcomes.

Innovative drugs that boost immunity are extending life for lung cancer patients, and an experimental vaccine may potentially prevent the disease entirely. The study was published in Nature on May 27, 2026.

The article highlights that Africa's reported low lung cancer rates are misleading due to inaccurate data collection, which misrepresents the health of people of African descent globally. Inaccurate data fails to capture true health trends, affecting both local and international populations.

The article from Nature, published on May 27, 2026, highlights recent advancements in lung-cancer research, including treatment breakthroughs and improved screening methods. Key developments from studies are emphasized as significant progress in the field.

AI and simple blood tests may enable earlier detection of lung cancer, offering a potential solution to expand screening access in the United States where current methods are limited.

The NHS has implemented a scheme using supermarket scans to detect thousands of lung cancer cases earlier. This initiative leverages consumer data to identify potential health risks and improve early diagnosis rates.